Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Conditions:   Gastrointestinal Tumors;   Colorectal Adenocarcinomas;   Gastric Adenocarcinomas;   Esophageal Adenocarcinomas Interventions:   Drug: PF-07062119;   Drug: Anti-PD1;   Drug: Anti-VEGF Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials